[go: up one dir, main page]

ZA949929B - Sugar-coated pharmaceutical dosage unit. - Google Patents

Sugar-coated pharmaceutical dosage unit.

Info

Publication number
ZA949929B
ZA949929B ZA949929A ZA949929A ZA949929B ZA 949929 B ZA949929 B ZA 949929B ZA 949929 A ZA949929 A ZA 949929A ZA 949929 A ZA949929 A ZA 949929A ZA 949929 B ZA949929 B ZA 949929B
Authority
ZA
South Africa
Prior art keywords
sugar
dosage unit
pharmaceutical dosage
coated pharmaceutical
steroid
Prior art date
Application number
ZA949929A
Inventor
Pieter De Haan
Marcus Johannes Maria Deurloo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA949929B publication Critical patent/ZA949929B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to sugar-coated dosage units comprising a steroid having two hydrogen atoms at position 3 of the steroid skeleton, such as desogestrel, allylestrenol, ethylestrenol, or lynestrenol, to a process for the manufacture of such dosage units, and a use of sugar-coated compositions for providing stable dosage units comprising said steroid.
ZA949929A 1993-12-23 1994-12-13 Sugar-coated pharmaceutical dosage unit. ZA949929B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93203645 1993-12-23

Publications (1)

Publication Number Publication Date
ZA949929B true ZA949929B (en) 1995-08-23

Family

ID=8214236

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949929A ZA949929B (en) 1993-12-23 1994-12-13 Sugar-coated pharmaceutical dosage unit.

Country Status (16)

Country Link
US (1) US5662936A (en)
EP (1) EP0659432B1 (en)
JP (1) JPH07206681A (en)
KR (1) KR100330560B1 (en)
CN (1) CN1108929A (en)
AT (1) ATE155039T1 (en)
AU (1) AU685538B2 (en)
CA (1) CA2138451C (en)
DE (2) DE659432T1 (en)
DK (1) DK0659432T3 (en)
ES (1) ES2105501T3 (en)
FI (1) FI116035B (en)
GR (1) GR3024817T3 (en)
NO (1) NO305273B1 (en)
NZ (1) NZ270228A (en)
ZA (1) ZA949929B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
EP1488794A3 (en) * 1994-11-22 2005-04-20 Balance Pharmaceuticals, Inc. Methods of contraception
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
ATE195871T1 (en) * 1997-09-23 2000-09-15 Akzo Nobel Nv STEROID-CONTAINING DOSAGE FORMS WITH A STEROID-PROOF OVERHEAD
AU777278B2 (en) 1999-06-05 2004-10-07 Innovata Biomed Limited Delivery system
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
HUP0203626A2 (en) * 1999-10-11 2003-02-28 Ml Lab Plc Medicament delivery device with moisture resistant coating
US6254888B1 (en) * 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
AU4278301A (en) * 2000-03-27 2001-10-08 Kyowa Hakko Kogyo Co. Ltd. Easy-to-take granule
DE60116758T2 (en) * 2000-05-18 2006-11-02 Therics, Inc. Encapsulation of a toxic to a non-toxic region in an oral formulation
JP2002068965A (en) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd Single-layer sugar-coated tablet and method for producing the same
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
JP2007533387A (en) 2004-04-21 2007-11-22 イノベータ バイオメド リミテッド Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
US20080050605A1 (en) * 2004-10-15 2008-02-28 Rapp Knut M Pan Coating Process
JP4808453B2 (en) * 2005-08-26 2011-11-02 株式会社荏原製作所 Polishing method and polishing apparatus
WO2007035961A2 (en) * 2005-09-23 2007-03-29 Threshold Pharmaceuticals, Inc. Anti-cancer therapies
BR112013016376A2 (en) * 2010-12-29 2018-06-19 Nestec S.A. confectionery product comprising agglomerated oil powder
US20150157040A1 (en) * 2012-07-03 2015-06-11 Nestec S.A. Confectionery product comprising agglomerated oil powder
US20150290136A1 (en) * 2012-11-22 2015-10-15 Evonik Roehm Gmbh Process for preparing a granulated product from a powder composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736682A (en) * 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
KR950016715A (en) 1995-07-20
AU685538B2 (en) 1998-01-22
EP0659432B1 (en) 1997-07-09
US5662936A (en) 1997-09-02
JPH07206681A (en) 1995-08-08
CA2138451C (en) 2007-04-24
FI116035B (en) 2005-09-15
KR100330560B1 (en) 2002-09-05
CA2138451A1 (en) 1995-06-24
DE659432T1 (en) 1997-01-30
NO944991L (en) 1995-06-26
FI946043A0 (en) 1994-12-22
NO944991D0 (en) 1994-12-22
ES2105501T3 (en) 1997-10-16
AU8168494A (en) 1995-06-29
CN1108929A (en) 1995-09-27
DK0659432T3 (en) 1998-02-16
EP0659432A1 (en) 1995-06-28
DE69404116T2 (en) 1997-11-13
NZ270228A (en) 1995-09-26
NO305273B1 (en) 1999-05-03
GR3024817T3 (en) 1998-01-30
DE69404116D1 (en) 1997-08-14
ATE155039T1 (en) 1997-07-15
FI946043L (en) 1995-06-24

Similar Documents

Publication Publication Date Title
ZA949929B (en) Sugar-coated pharmaceutical dosage unit.
UA32512C2 (en) Xanthine derivatives, a PROCESS for PREPARATION thereof and A pharmaceutical composition
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
CA2304770A1 (en) A use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds
AU5587690A (en) Treatment of postmenopausal disorders
UA41909C2 (en) Use A combination of compounds for the inhibition of osteoporosis, a pharmaceutical agent
IL103516A0 (en) Cytotoxic bicyclo(7,3,1)tridec-4-ene-2,6-diyne compounds,process for the preparation thereof and pharmaceutical compositions containing them
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
GB9414966D0 (en) Pharmaceutical compositions for the nasal administration of antiviral agents
EP0221728A3 (en) Monosaccharide containing wound healing preparation
ZA941464B (en) Use of pregnane derivative
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
IL109866A (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it
ZA929879B (en) Compositions for the treatment of mammalian diseases.
GR1002576B (en) Pharmaceutical compositions and a process for the preparation thereof.
TW218011B (en)
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
ES2065855A1 (en) Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
ES8703872A1 (en) 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives.
HU9402237D0 (en) Use of benzene-sulfonyl-indol derivatives for producing pharmaceutical compositions
ES2184285T3 (en) PHARMACEUTICAL COMPOUNDS CONTAINING CINCONINE DICHLORHYDRATE.
AU1067795A (en) Use of lithium compounds in the treatment and prevention of alzheimer's disease
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins